LOGIN  |  REGISTER
Amneal Pharmaceuticals

Recent Insider Transactions - Supernus Pharmaceuticals (NASDAQ: SUPN)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ SUPN Supernus Pharmaceuticals
Khattar Jack A. / director, officer: President, CEO
03/10/2025
Sell
$32.06
16,805
$539K
991,833
NASDAQ SUPN Supernus Pharmaceuticals
DEC TIMOTHY C / officer: Senior Vice-President & CFO
03/10/2025
Sell
$32.06
955
$31K
12,681
NASDAQ SUPN Supernus Pharmaceuticals
DEC TIMOTHY C / officer: Senior Vice-President & CFO
03/10/2025
Sell
$32.06
1,062
$34K
11,836
NASDAQ SUPN Supernus Pharmaceuticals
Khattar Jack A. / director, officer: President, CEO
03/07/2025
Sell
$39.11
18,581
$727K
973,638
NASDAQ SUPN Supernus Pharmaceuticals
Mottola Frank / officer: SVP, Quality, GMP, Ops, IT
03/07/2025
Sell
$39.11
1,356
$53K
15,151
NASDAQ SUPN Supernus Pharmaceuticals
DEC TIMOTHY C / officer: Senior Vice-President & CFO
03/05/2025
Sell
$33.05
276
$9K
13,815
NASDAQ SUPN Supernus Pharmaceuticals
DEC TIMOTHY C / officer: Senior Vice-President & CFO
03/05/2025
Sell
$33.05
1,587
$52K
12,228
NASDAQ SUPN Supernus Pharmaceuticals
DEC TIMOTHY C / officer: Senior Vice-President & CFO
03/05/2025
Sell
$33.05
1,330
$44K
10,898
NASDAQ SUPN Supernus Pharmaceuticals
Bhatt Padmanabh P. / officer: Sr. VP of IP, CSO
03/05/2025
Sell
$33.05
335
$11K
13,854
NASDAQ SUPN Supernus Pharmaceuticals
Bhatt Padmanabh P. / officer: Sr. VP of IP, CSO
03/05/2025
Sell
$33.05
575
$19K
13,279
NASDAQ SUPN Supernus Pharmaceuticals
Bhatt Padmanabh P. / officer: Sr. VP of IP, CSO
03/05/2025
Sell
$33.05
575
$19K
12,704
NASDAQ SUPN Supernus Pharmaceuticals
Mottola Frank / officer: SVP, Quality, GMP, Ops, IT
03/05/2025
Sell
$33.05
337
$11K
15,437
NASDAQ SUPN Supernus Pharmaceuticals
Mottola Frank / officer: SVP, Quality, GMP, Ops, IT
03/05/2025
Sell
$33.05
610
$20K
14,827
NASDAQ SUPN Supernus Pharmaceuticals
Mottola Frank / officer: SVP, Quality, GMP, Ops, IT
03/05/2025
Sell
$33.05
945
$31K
13,882
NASDAQ SUPN Supernus Pharmaceuticals
Rubin Jonathan / officer: SVP, Chief Medical Officer
03/05/2025
Sell
$33.05
314
$10K
10,789
NASDAQ SUPN Supernus Pharmaceuticals
Rubin Jonathan / officer: SVP, Chief Medical Officer
03/05/2025
Sell
$33.05
577
$19K
10,212
NASDAQ SUPN Supernus Pharmaceuticals
Rubin Jonathan / officer: SVP, Chief Medical Officer
03/05/2025
Sell
$33.05
577
$19K
9,635
NASDAQ SUPN Supernus Pharmaceuticals
Mottola Frank / officer: SVP, Quality, GMP, Ops, IT
02/26/2025
Sell
$39.48
1,909
$75K
15,774
NASDAQ SUPN Supernus Pharmaceuticals
Mottola Frank / officer: SVP, Quality, GMP, Ops, IT
02/26/2025
Sell
$39.48
976
$39K
13,933
NASDAQ SUPN Supernus Pharmaceuticals
Bhatt Padmanabh P. / officer: Sr. VP of IP, CSO
02/21/2025
Sell
$39.15
860
$34K
10,939
NASDAQ SUPN Supernus Pharmaceuticals
Rubin Jonathan / officer: SVP, Chief Medical Officer
02/21/2025
Sell
$39.15
927
$36K
7,853
NASDAQ SUPN Supernus Pharmaceuticals
Mottola Frank / officer: SVP, Quality, GMP, Ops, IT
02/21/2025
Sell
$39.15
552
$22K
9,024
NASDAQ SUPN Supernus Pharmaceuticals
Mottola Frank / officer: SVP, Quality, GMP, Ops, IT
02/19/2025
Buy
$33.52
20,000
$670K
20,000
NASDAQ SUPN Supernus Pharmaceuticals
Hudson Frederick M. / director
02/19/2025
Buy
$33.52
7,296
$245K
7,296
NASDAQ SUPN Supernus Pharmaceuticals
NEWHALL CHARLES W III / director
02/19/2025
Buy
$33.52
7,296
$245K
7,296
NASDAQ SUPN Supernus Pharmaceuticals
GEMAYEL GEORGES / director
02/19/2025
Buy
$33.52
7,296
$245K
7,296
NASDAQ SUPN Supernus Pharmaceuticals
Sensenig Bethany / director
02/19/2025
Buy
$33.52
7,296
$245K
7,296
NASDAQ SUPN Supernus Pharmaceuticals
Barlow Carrolee / director
02/19/2025
Buy
$33.52
7,296
$245K
7,296
NASDAQ SUPN Supernus Pharmaceuticals
Bhatt Padmanabh P. / officer: Sr. VP of IP, CSO
02/19/2025
Buy
$33.52
20,000
$670K
20,000
NASDAQ SUPN Supernus Pharmaceuticals
Rubin Jonathan / officer: SVP, Chief Medical Officer
02/19/2025
Buy
$33.52
20,000
$670K
20,000
NASDAQ SUPN Supernus Pharmaceuticals
DEC TIMOTHY C / officer: Senior Vice-President & CFO
02/19/2025
Buy
$33.52
40,000
$1.341M
40,000
NASDAQ SUPN Supernus Pharmaceuticals
Khattar Jack A. / director, officer: President, CEO
02/20/2025
Buy
$34.59
331,660
$11.472M
331,660